Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 11, 1998, Pages 2411-2422

  Ohnishi, Hiromichi ^a   Oka, Takefumi ^a   Kusachi, Shozo ^a   Nakanishi, Tohru ^b   Takeda, Kenji ^a   Nakahama, Makoto ^a   Doi, Masayuki ^a   Murakami, Takashi ^a   Ninomiya, Yoshifumi ^a   Takigawa, Masaharu ^b   Tsujin, Takao ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Electrophoresis; Extracellular matrix; Immunohistochemistry; Ischemic heart disease; Molecular biology

Indexed keywords

GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CONNECTIVE TISSUE; GRANULATION TISSUE; IMMUNOBLOTTING; LEFT CORONARY ARTERY; MALE; MESENCHYME CELL; MUSCLE CELL; MYOFIBROBLAST; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0032211854     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0799     Document Type: Article

References (34)

1. ASSOIAN RK, KOMORIYA A, MEYERS CA, MILLER DM, SPORN MB, 1983. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258: 7155-7160.
2. ASSOIAN RK, FLEURDELYS BE, STEVENSON HC, MILLER PJ, MADTES DK, RAINES EW, ROSS R, SPORN MB, 1987. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84: 6020-6024.
3. BORNSTEIN P, SAGE H, 1980. Structurally distinct collagen types. Annu Rev Biochem 49: 957-1003.
4. BRADHAM DM, IGARASHI A, POTTER RL, GROTENDORST GR, 1991. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294.
5. 1 in normal heart and in myocardial infarction. Ann NY Acad Sci 593: 148-160.
6. CASSCELLS W, KIMURA H, SANCHEZ J, FERRANS V, 1990b. Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol 137: 801-810.
7. CHEN WT, WANG J, HASEGAWA T, YAMADA SS, YAMADA KM, 1986. Regulation of fibronectin receptor distribution by transformation, exogenous fibronectin, and synthetic peptides. J Cell Biol 103: 1649-1661.
8. COMPTON SJ, JONES CG, 1985. Mechanism of dye response and interference in the Bradford protein assay. Anal Biochem 151: 369-374.
9. FALANGA V, QIAN SW, DANIELPOUR D, KATZ MH, ROBERTS AB, SPORN MB, 1991. Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J Invest Dermatol 97: 634-637.
10. FALANGA V, MARTIN TA, TAKAGI H, KIRSNER RS, HELFMAN T, PARDES J, 1993. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human delmal fibroblasts. J Cell Physiol 157: 408-412.
11. FALKENHAHN M, FRANKE F, BOHLE RM, ZHU YC, STAUSS HM, BACHMANN S, DANILOV S, UNGER T, 1995. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 25: 219-226.
12. FISHBEIN MC, MACLEAN D, MAROKO PR, 1978. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90: 57-70.
13. FRAZIER K, WILLIAMS S, KOTHAPALLI D, KLAPPER H, GROTENDORST GR, 1996. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107: 404-411.
14. GROTENDORST GR, OKOCHI H, HAYASHI N, 1996. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell Growth & Differentiation 7: 469-480.
15. GROTENDORST GR, SMALE G, PENCEV D, 1989. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 140: 396-402.
16. HIGASHI T, TAKECHI H, UEMURA Y, KIKUCHI H, NAGATA K, 1994. Differential induction of mRNA species encoding several classes of stress proteins following focal cerebral ischemia in rats. Brain Res 650: 239-248.
17. IGARASHI A, OKOCHI H, BRADHAM DM, GROTENDORST GR, 1993. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4: 637-645.
18. JUGDUTT BI, 1993. Prevention of ventricular remodeling post myocardial infarction: Timing and duration of therapy. Can J Cardiol 9: 103-114.
19. KOSTUK WJ, KAZAMIAS TM, GANDER MP, SIMON AL, ROSS J, 1973. Left ventricular size after acute myocardial infarction: serial changes and their prognostic significance. Circulation 47: 1174-1179.
20. LASER A, NEUBAUER S, TIAN R, HU K, GAUDRON P, INGWALL JS, ERTL G, 1996. Long-Term β-Blocker Treatment Prevents Chronic Creatine Kinase and Lactate Dehydrogenase System Changes in Rat Hearts After Myocardial Infarction. J Am Coll Cardiol 27: 487-493.
21. LINSENMAYER TF, 1991. Collagen. In Cell Biology of Extracellular Matrix, 2nd edn. Edited by Hay ED. New York: Plenum: 7-44.
22. MATRISIAN LM, 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125.
23. NAKANISHI T, KIMURA Y, TAMURA T, ICHIKAWA H, YAMAAI Y, SUGIMOTO T, TAKIGAWA M, 1997. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem Biophys Res Comm 234: 206-210.
24. NISHIDA T, NAKANISHI T, SHIMO T, ASANO M, HATTORI T, TAMATANI T, TEZUKA K, TAKIGAWA M, 1998. Demonstration of receptors specific for connective tissue growth factor on a human chondrocyte cell line (HCS-2/8). Biochem Biophys Res Commun 247: 905-909.
25. OEMAR BS, WERNER A, GARNIER JM, DO DD, GODOY N, NAUCK M, MARZ W, RUPP J, PECH M, LUSCHER TF, 1997. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 95: 831-839.
26. PERRYMAN MB, YU QT, MARIAN AJ, MARES A JR, CZERNUSZEWICZ G, IFEGWU J, HILL R, ROBERTS R, 1992. Expression of a missense mutation in the messenger RNA for β-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. J Clin Invest 90: 271-277.
27. PFEFFER MA, BRAUNWALD E, 1990. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172.
28. SELYE H, BAJUSZ E, GRASSO S, MENDELL P, 1960. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11: 398-407.
29. SHIMO T, NAKANISHI T, KIMURA Y, NISHIDA T, ISHIZEKI K, MATSUMURA T, TAKIGAWA M, 1998. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem (Tokyo) 124: 130-140.
30. SUN Y, WEBER KT, 1996. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 28: 851-858.
31. THOMPSON NL, BAZOBERRY F, SPEIR EH, CASSCELLS W, FERRANS VJ, FLANDERS KC, KONDAIAH P, GEISER AG, SPORN MB, 1988. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors 1: 91-99.
32. WEISMAN HF, HEALY B, 1987. Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts. Prog Cardiovasc Dis 30: 73-110.
33. WHITE HD, NORRIS RM, BROWN MA, BRANDT PWT, WHITELOCK RML, WILD CJ, 1987. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76: 44-51.
34. WHITEHEAD TP, KRICKA LJ, CARTER TJ, THORPE GH, 1979. Analytical luminescence: its potential in the clinical laboratory. Clin Chem 25: 1531-1546.